A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.

Name: A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
License: Public Domain

Zogenix, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

cdkl5 deficiency disorder, generalized tonic clonic seizure, epileptic spasm, refractory seizures

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 290885
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.